GO:0032218 riboflavin transport: Genes, Functions & Research

Riboflavin, also known as vitamin B2, is an essential water-soluble vitamin that serves as a precursor for the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These flavin cofactors are required for the function of numerous flavoproteins involved in oxidative phosphorylation, fatty acid oxidation, and redox reactions. Because humans cannot synthesize riboflavin, its uptake from dietary sources and distribution to tissues depend on specific transport mechanisms. The Gene Ontology term GO:0032218, riboflavin transport, captures the directed movement of riboflavin into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental for maintaining cellular flavin homeostasis and preventing riboflavin deficiency disorders. Research over the past decade has identified the molecular players responsible for riboflavin transport, particularly the SLC52A family of riboflavin transporters (RFVTs). These transporters are expressed in various tissues, including the intestine, kidney, brain, and retina, where they mediate riboflavin uptake and distribution. Structural and functional studies have elucidated the transport mechanism of human riboflavin transporters, revealing how they recognize and translocate riboflavin across membranes. Dysregulation of riboflavin transport has been implicated in inherited diseases such as Brown-Vialetto-Van Laere syndrome and in drug-induced or toxicant-induced perturbations. Understanding GO:0032218 is therefore crucial for researchers studying vitamin metabolism, neurobiology, and therapeutic interventions. This article provides a comprehensive overview of riboflavin transport, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental approaches. It is intended for researchers seeking to investigate riboflavin transport using CRISPR-based models and other molecular techniques.

GO:0032218 riboflavin transport is defined as the directed movement of riboflavin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin that is converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins.

Riboflavin transport is essential for supplying cells with vitamin B2, which is a precursor to FMN and FAD, cofactors required for the function of flavoproteins involved in energy metabolism, redox homeostasis, and cellular growth. Defects in riboflavin transport lead to riboflavin deficiency and severe neurological disorders such as Brown-Vialetto-Van Laere syndrome. Moreover, riboflavin transporters at the blood-retinal barrier are critical for maintaining retinal health. Understanding the regulation and dysfunction of riboflavin transport is therefore important for developing therapeutic strategies for related diseases and for interpreting drug-drug interactions.

The following genes and proteins are central to riboflavin transport, including transporters, enzymes, and regulatory factors.

Riboflavin transport is regulated at multiple levels. Transcriptional regulation of SLC52A genes can be influenced by nutritional status and cellular stress. Post-translational modifications and membrane trafficking of transporters may also modulate transport activity. Additionally, riboflavin transport can be inhibited by drugs such as ticagrelor, which affects BCRP and MRP4. Inflammatory cytokines like IL-17A can regulate riboflavin transport in the context of fluoride exposure. These regulatory mechanisms ensure that riboflavin homeostasis is maintained under varying physiological conditions.

Brown-Vialetto-Van Laere syndrome is a rare neurological disorder characterized by pontobulbar palsy, sensorineural deafness, and respiratory insufficiency. It is caused by mutations in SLC52A2 (RFVT2) and SLC52A3 (RFVT3), leading to impaired riboflavin transport and reduced intracellular flavin levels. High-dose riboflavin supplementation can improve symptoms in some patients, highlighting the importance of transport function.

Defects in riboflavin transport can lead to riboflavin deficiency, which manifests as anemia, skin disorders, and neurological symptoms. Disorders of riboflavin metabolism, including those affecting transport, are increasingly recognized as causes of metabolic and neurodegenerative diseases.

Ticagrelor, an antiplatelet drug, inhibits riboflavin transport by BCRP and MRP4, leading to increased plasma riboflavin levels. This interaction may affect riboflavin status in patients and underscores the need to consider drug-transporter interactions in clinical settings.

Fluoride exposure has been shown to regulate riboflavin transport and metabolism in the spleen, partly through IL-17A, contributing to immunotoxicity. This highlights the role of riboflavin transport in immune function and environmental health.

Riboflavin transport activity can be measured using radiolabeled or fluorescent riboflavin in cell-based assays. Cells expressing specific transporters (e.g., SLC52A2) are incubated with riboflavin, and uptake is quantified by scintillation counting or fluorescence detection. These assays are used to study kinetics, substrate specificity, and inhibition by drugs.

Quantitative RT-PCR and RNA-seq can measure the expression levels of SLC52A genes and related metabolic enzymes under different conditions. This helps identify transcriptional regulation of riboflavin transport in response to nutrients, drugs, or toxicants.

Immunofluorescence and subcellular fractionation can determine the localization of riboflavin transporters in tissues such as the blood-retinal barrier. Co-immunoprecipitation and proximity ligation assays can identify interacting proteins.

Genome-wide CRISPR knockout screens can identify genes that regulate riboflavin transport or are essential for cell survival under riboflavin-limited conditions. These screens can uncover novel transporters or regulatory pathways.

Researchers studying riboflavin transport-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect function, and what cellular pathways are impacted. EDITGENE provides comprehensive CRISPR-based services to address these questions, from knockout and point-mutation models to overexpression and library screening.

Riboflavin transport (GO:0032218) is a fundamental biological process that ensures cellular supply of vitamin B2 for the synthesis of FMN and FAD. The SLC52A family of transporters plays a central role, and their dysfunction is linked to severe diseases such as Brown-Vialetto-Van Laere syndrome. Understanding the mechanisms, regulation, and disease relevance of riboflavin transport is essential for developing therapeutic strategies. EDITGENE provides advanced CRISPR tools to model and study riboflavin transport-related genes, empowering researchers to uncover new insights.